Thibault Boutherin
Stock Analyst at Morgan Stanley
(1.56)
# 3,015
Out of 5,040 analysts
4
Total ratings
50%
Success rate
0.51%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALVO Alvotech | Upgrades: Overweight | $14 | $8.12 | +72.41% | 2 | Oct 14, 2025 | |
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $53.21 | -11.67% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $19.06 | -47.53% | 1 | May 25, 2023 |
Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $8.12
Upside: +72.41%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $53.21
Upside: -11.67%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $19.06
Upside: -47.53%